These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4682676)

  • 1. Defective release of growth hormone in parkinsonism improved by levodopa.
    Mena I; Cotzias GC; Brown FC; Papavasiliou PS; Miller ST
    N Engl J Med; 1973 Feb; 288(6):320-1. PubMed ID: 4682676
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
    Perlow MJ; Sassin JF; Boyar R; Hellman L; Weitzman ED
    Dis Nerv Syst; 1972 Dec; 33(12):804-10. PubMed ID: 4668972
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of human-growth-hormone secretion by L-dopa.
    Boyd AE; Lebovitz HE; Pfeiffer JB
    N Engl J Med; 1970 Dec; 283(26):1425-9. PubMed ID: 5481776
    [No Abstract]   [Full Text] [Related]  

  • 4. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
    Massara F; Camanni F; Molinatti GM
    Horm Metab Res; 1973 Nov; 5(6):454-6. PubMed ID: 4767002
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
    Sirtori CR; Bolme P; Azarnoff DL
    N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacological control of growth hormone release. Studies on the action of L-dopa and chlorpromazine in normal subjects and patients with Parkinsonism, acromegaly and delayed onset of puberty.
    Singh P; McDevitt D; Mackay J; Hadden DR
    J Endocrinol; 1973 Jul; 58(1):xii. PubMed ID: 4722544
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
    Kansal PC; Buse J; Talbert OR; Buse MG
    J Clin Endocrinol Metab; 1972 Jan; 34(1):99-105. PubMed ID: 5061778
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma DOPA and growth hormone in parkinsonism: oscillations in symptoms.
    Papavasiliou PS; McDowell FH; Wang YY; Rosal V; Miller ST
    Neurology; 1979 Feb; 29(2):194-200. PubMed ID: 571063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic responses to levodopa.
    N Engl J Med; 1972 Dec; 287(25):1302-3. PubMed ID: 4636900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F; Pontiroli AE; Raggi U; Peracchi M; Malinverni A
    Folia Endocrinol; 1973 Dec; 26(6):483-9. PubMed ID: 4801258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
    Sakoda M; Kusaka T; Baba S; Shirakata S
    Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-dopa on plasma growth hormones and insulin.
    Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
    Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1974; 6(2):89-93. PubMed ID: 4837060
    [No Abstract]   [Full Text] [Related]  

  • 14. More on levodopa--implications for adrenal function.
    Greenberg SR
    N Engl J Med; 1972 Feb; 286(7):375-6. PubMed ID: 4332797
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
    Imura H; Nakai Y; Matsukura S; Matsuyama H
    Horm Metab Res; 1973 Jan; 5(1):41-5. PubMed ID: 4706921
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Enhancement of levodopa-induced growth-hormone stimulation by propranolol.
    Camanni F; Massara F
    Lancet; 1974 May; 1(7863):942. PubMed ID: 4133478
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of plasma concentrations of levodopa to clinical response in Parkinsonsim.
    Allen JG; Calne DB; Davies CA; Reid JL
    Br J Pharmacol; 1971 Oct; 43(2):464P-465P. PubMed ID: 5158238
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and limitations of long-term levodopa therapy in Parkinsonism.
    Celesia GG; Barr AN
    Wis Med J; 1970 Oct; 69(10):227-9. PubMed ID: 5472626
    [No Abstract]   [Full Text] [Related]  

  • 20. [Levodopa treatment in parkinsonism].
    Rinne UK; Sonninen V; Siirtola T
    Duodecim; 1971; 87(12):933-47. PubMed ID: 5088232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.